Pfizer AstraZeneca takeover: Vince Cable on collision course with Tories over £63bn bid for pharma giant

Business Secretary says Britain’s future is ‘not a tax haven’ and priority is jobs

Vince Cable is on a collision course with Tory ministers after threatening to block a proposed £63bn takeover of one of Britain’s largest companies.

The potential deal between AstraZeneca and Pfizer has been championed by the Conservatives but the Business Secretary said he would not rule out intervention if the US giant fails to produce “binding” promises to protect jobs and scientific research.

While the Tories last week hailed the proposed takeover as evidence that Britain’s low-tax economy could attract major foreign investment, the Liberal Democrat minister appeared to distance himself from his Coalition partner.

“We see the future of the UK as a knowledge economy, not as a tax haven,” Mr Cable said. Critics have raised fears that Pfizer is trying to acquire AstraZeneca as a way of reducing its tax bill in the United States and as a prelude to breaking up its business into three parts.

Attempts by Pfizer to acquire AstraZeneca, Britain’s second-largest pharmaceutical company with nearly 7,000 employees in the UK, have moved to the top of the political agenda and are exposing Coalition strains.

Labour has accused David Cameron of acting like a “cheerleader” for the possible acquisition after he said Pfizer had produced “robust” assurances over its intentions.

Read more: AstraZeneca will fall to Pfizer once the price is right, even if British politicians are jumping up and down

Ed Miliband, the party leader, has called on the Coalition to extend the national interest test on takeovers to safeguard the country’s science base.

Two parliamentary select committees announced they planned to summon managers from both companies as part of an investigation into the deal, which would be the largest takeover in British corporate history. Sir David Barnes, the former chief executive of AstraZeneca, spoke of his alarm that Pfizer would behave like a “praying mantis” and would “suck the lifeblood out of their prey”.

Mr Cable told the Commons he was taking a “studiously neutral” approach to the potential deal, arguing he would be governed on what was best for jobs and protecting scientific research in Britain. The Business Secretary raised the prospect of extending the Government’s public-interest powers to cover the pharmaceutical or science sectors. They are currently limited to intervention in the financial sector, to ensuring media plurality and protecting national security.

The Business Secretary, Vince Cable (Getty) The Business Secretary, Vince Cable (Getty)
However, that would be seen as a last resort as it would require legislation to amend the 2002 Enterprise Act.

Mr Cable said: “One of our options would be to consider using our public-interest test powers – or even expanding them. This would be a serious step and not one that should be taken lightly.

“I am open-minded about it, but should stress we are operating within serious European legal constraints.”

He said talks with Pfizer were aimed at ensuring any promises they gave about AstraZeneca’s operations in the UK would be “binding”.

Mr Cable said: “Should this proceed, clearly there will be negotiations to make sure any obligation is binding. I’m sure Pfizer themselves would want to ensure any obligations are clear and binding.”

But Chuka Umunna, the shadow Business Secretary, argued that Pfizer could not be trusted to keep any promises it made about its intentions.

He said: “The assurances the Government has extracted from Pfizer are simply not worth the paper they are written on. The main rationale for this transaction appears to be tax.”

Shadow Business Secretary Chuka Umunna doesn't believe Pfizer can be trusted (PA) Shadow Business Secretary Chuka Umunna doesn't believe Pfizer can be trusted (PA)
The Chancellor George Osborne yesterday tempered his initial enthusiasm for the proposed takeover, saying that “our sole interest here is in securing good jobs in Britain, good manufacturing jobs, good science jobs”.

But the Tory Mayor of London, Boris Johnson, added to the pressure on Tory ministers by saying they cannot “be entirely aloof from this”.

“It would be very important to establish that Pfizer is genuinely committed to research and development in this country,” he said.

AstraZeneca has twice rebuffed approaches from Pfizer, saying its latest £63bn offer “substantially undervalued” its real worth.

Its chief executive, Pascal Soriot, warned yesterday that the takeover plan would jeopardise its “fragile” but ambitious drug discovery programme. He said: “I have been through enough mergers to know a company is not a machine. It is a group of people. If you disrupt their work you can really have a negative impact very quickly.”

Mr Soriot declared the company would grow annual sales to more than £26bn by 2023 from the current £15.1bn, thanks largely to its pipeline of new medicines being developed. It was just that process of creating new drugs that would be jeopardised by a takeover, he said.

AstraZeneca has gone from having 57 drugs in 2012 to having 84 now, as it has moved quickly to boost its development programme. Analysts say that, as well as the UK tax status, is what attracted Pfizer to make its bid.

What they say about Pfizer

“I have a great concern that they will act like a praying mantis and suck the lifeblood out of their prey” Sir David Barnes, former chief  executive of AstraZeneca

“Pfizer has said it is committed to making a long-term investment in the UK through this purchase. Similar assurances were given to other companies acquired by Pfizer in the US and in Sweden. Subsequently, research facilities were shut down and thousands of high-skilled jobs lost.” Chuka Umunna, shadow Business Secretary

“I am concerned about the future of AstraZeneca’s planned move to Cambridge which involves an investment of £330m on site and jobs for 2,000 people. And I am worried about Pfizer’s future plans in the UK which have implications for our economy as a whole.” Julian Huppert, Lib Dem MP for Cambridge

“We are not convinced that Pfizer’s bid is anything more than an attempt by a US company to reduce its taxes by buying into a UK-owned company.” Unite national  officer Linda McCulloch

Start your day with The Independent, sign up for daily news emails
Have you tried new the Independent Digital Edition apps?
ebooks
ebooksA special investigation by Andy McSmith
Voices
An easy-peel potato; Dave Hax has come up with an ingenious method in food preparation
voicesDave Hax's domestic tips are reminiscent of George Orwell's tea routine. The world might need revolution, but we like to sweat the small stuff, says DJ Taylor
News
i100
Arts and Entertainment
Jay Z has placed a bet on streaming being the future for music and videos
music
Arts and Entertainment
Festival-goers soak up the atmosphere at Glastonbury
music
News
Japan's population is projected to fall dramatically in the next 50 years (Wikimedia)
news
  • Get to the point
2015 General Election
May2015

Poll of Polls

Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Recruitment Genius: Project Implementation Executive

£18000 - £23000 per annum: Recruitment Genius: They work with major vehicle ma...

Recruitment Genius: Chiropractic Assistant

£16500 per annum: Recruitment Genius: A Chiropractic Assistant is needed in a ...

Recruitment Genius: Digital Account Executive - Midlands

£18000 - £26000 per annum: Recruitment Genius: They work with major vehicle ma...

Recruitment Genius: Web Developer

£28000 - £30000 per annum: Recruitment Genius: This company provides coaching ...

Day In a Page

NHS struggling to monitor the safety and efficacy of its services outsourced to private providers

Who's monitoring the outsourced NHS services?

A report finds that private firms are not being properly assessed for their quality of care
Zac Goldsmith: 'I'll trigger a by-election over Heathrow'

Zac Goldsmith: 'I'll trigger a by-election over Heathrow'

The Tory MP said he did not want to stand again unless his party's manifesto ruled out a third runway. But he's doing so. Watch this space
How do Greek voters feel about Syriza's backtracking on its anti-austerity pledge?

How do Greeks feel about Syriza?

Five voters from different backgrounds tell us what they expect from Syriza's charismatic leader Alexis Tsipras
From Iraq to Libya and Syria: The wars that come back to haunt us

The wars that come back to haunt us

David Cameron should not escape blame for his role in conflicts that are still raging, argues Patrick Cockburn
Sam Baker and Lauren Laverne: Too busy to surf? Head to The Pool

Too busy to surf? Head to The Pool

A new website is trying to declutter the internet to help busy women. Holly Williams meets the founders
Heston Blumenthal to cook up a spice odyssey for British astronaut manning the International Space Station

UK's Major Tum to blast off on a spice odyssey

Nothing but the best for British astronaut as chef Heston Blumenthal cooks up his rations
John Harrison's 'longitude' clock sets new record - 300 years on

‘Longitude’ clock sets new record - 300 years on

Greenwich horologists celebrate as it keeps to within a second of real time over a 100-day test
Fears in the US of being outgunned in the vital propaganda wars by Russia, China - and even Isis - have prompted a rethink on overseas broadcasters

Let the propaganda wars begin - again

'Accurate, objective, comprehensive': that was Voice of America's creed, but now its masters want it to promote US policy, reports Rupert Cornwell
Why Japan's incredible long-distance runners will never win the London Marathon

Japan's incredible long-distance runners

Every year, Japanese long-distance runners post some of the world's fastest times – yet, come next weekend, not a single elite competitor from the country will be at the London Marathon
Why does Tom Drury remain the greatest writer you've never heard of?

Tom Drury: The quiet American

His debut was considered one of the finest novels of the past 50 years, and he is every bit the equal of his contemporaries, Jonathan Franzen, Dave Eggers and David Foster Wallace
You should judge a person by how they peel a potato

You should judge a person by how they peel a potato

Dave Hax's domestic tips are reminiscent of George Orwell's tea routine. The world might need revolution, but we like to sweat the small stuff, says DJ Taylor
Beige is back: The drab car colours of the 1970s are proving popular again

Beige to the future

Flares and flounce are back on catwalks but a revival in ’70s car paintjobs was a stack-heeled step too far – until now
Bill Granger recipes: Our chef's dishes highlight the delicate essence of fresh cheeses

Bill Granger cooks with fresh cheeses

More delicate on the palate, milder, fresh cheeses can also be kinder to the waistline
Aston Villa vs Liverpool: 'This FA Cup run has been wonderful,' says veteran Shay Given

Shay Given: 'This FA Cup run has been wonderful'

The Villa keeper has been overlooked for a long time and has unhappy memories of the national stadium – but he is savouring his chance to play at Wembley
Timeless drama of Championship race in league of its own - Michael Calvin

Michael Calvin's Last Word

Timeless drama of Championship race in league of its own